Meroanencephaly

Meroanencephaly is a rare, “partial” form of anencephaly, a severe open neural tube defect (NTD) where parts of the skull and brain do not form normally. In meroanencephaly, the top midline of the skull is missing and abnormal, spongy vascular tissue called the area cerebrovasculosa lies exposed where normal brain should be; only some elements of the brainstem or midbrain may be present. This condition sits within the anencephaly spectrum (meroanencephaly, holoanencephaly, and craniorachischisis), and—like all anencephaly types—is not compatible with long-term survival. Diagnosis is usually made by prenatal ultrasound, and management centers on counseling, birth planning, and perinatal palliative care. NCBI+4PubMed+4PMC+4

Meroanencephaly is a severe birth defect of the brain and skull. It happens when the upper end of the “neural tube”—the early structure that forms the brain and spine—fails to close correctly in the first month after conception. In mero-anencephaly (“partial” anencephaly), there is a partial absence of the brain and skull. A thin, abnormal layer of tissue (called the “area cerebrovasculosa”) may cover the exposed area. It belongs to the spectrum of anencephaly, which is an “open” neural tube defect. CDC Archive+2PubMed+2

Because closure fails so early, the skull vault cannot form normally and parts of the forebrain are missing. The remaining lower brain structures (brainstem) may still function for a short time. Meroanencephaly is therefore “partial” anencephaly, while holoanencephaly is “total.” Craniorachischisis is the most severe form, where the open defect also extends down the spine. CDC Archive+2CDC Archive+2

Other names

Doctors may also describe meroanencephaly as “partial anencephaly,” “merocrania,” or “classic anencephaly.” All these terms refer to the same idea: a partial absence of brain and skull in the anencephaly spectrum. (Radiology sources often use merocrania.) Radiopaedia+1

Types

1) Meroanencephaly (partial anencephaly).
Some skull and skin may be present; rudimentary brain tissue may be seen. The cranial defect is often in the midline near the top of the head. PubMed+1

2) Holoanencephaly (total anencephaly).
Most or all of the brain above the brainstem is absent; this is the most common type in large surveillance systems. CDC Archive

3) Craniorachischisis.
An open anencephaly that continues down the spine with an open spinal cord (rachischisis). This is the most severe type. CDC Archive

Causes and risk factors

Neural tube defects are usually multifactorial—caused by a mix of genes, nutrition, medicines, and environment. Prevention with folic acid before and during early pregnancy is strongly protective. PubMed+2Office of Dietary Supplements+2

1. Low folate (folic acid) intake.
   Not getting enough folic acid before conception and in the first 4 weeks of pregnancy raises risk. This is why 400–800 micrograms daily is recommended for people who could become pregnant. CDC+1

2. Previous baby with a neural tube defect (family history).
   Having had one pregnancy affected by an NTD raises the chance in a later pregnancy. Children’s Hospital of Philadelphia

3. Pre-existing diabetes that is not well controlled.
   High blood sugar early in pregnancy is linked to neural tube defects. Good control reduces risk. CDC

4. Obesity before pregnancy.
   Higher pre-pregnancy BMI is associated with increased NTD risk in population studies. PMC

5. Maternal hyperthermia (high temperature) in the first weeks.
   Fever or hot-tub/sauna overheating during very early pregnancy is linked to NTDs. PubMed+1

6. Certain anti-seizure medicines (especially valproate).
   Valproate has a well-proven association with NTDs; alternatives are often preferred in pregnancy planning. U.S. Food and Drug Administration+1

7. Vitamin B12 deficiency.
   Low B12 levels are associated with higher NTD risk; B12 works with folate in one-carbon metabolism. PMC+1

8. Genetic variants in neural tube closure pathways (e.g., planar cell polarity genes).
   Research has linked mutations in PCP/WNT genes (e.g., VANGL1/2, FZD6) to human NTDs. PubMed+1

9. Folate-antagonist medications.
   Some drugs interfere with folate pathways (e.g., certain antimetabolites), which can raise risk if taken around conception. (General mechanism summarized here.) PubMed

10. Malabsorption or diets low in animal products without supplementation.
    Celiac disease or strict vegan diets without B12 can lead to low folate/B12 status. Genome.gov

11. Low socioeconomic access to fortified foods/supplements.
    Lower access can reduce preconception folate intake; folate fortification policies were adopted to prevent NTDs. CDC

12. Use of multiple teratogenic medicines.
    Some combinations (e.g., valproate plus others) may increase risk more than a single agent. Careful pre-pregnancy counseling is essential. PMC

13. Maternal illnesses that raise body temperature.
    Prolonged early fever itself—not just hot tubs—can raise risk. Treat fevers appropriately and avoid overheating. PubMed

14. Zinc or other micronutrient deficiencies (emerging evidence).
    Systematic reviews note associations with zinc deficiency and NTDs, though folate remains the key preventive nutrient. PMC

15. Exposure to certain environmental toxins (general risk concept).
    Some studies suggest associations with pesticides/solvents, but findings vary; nutritional prevention is still central. PubMed

16. Maternal age extremes (possible association).
    Some surveillance data suggest slightly altered risk at very young or older ages, but the effect is smaller than folate or medicines. PubMed

17. Short inter-pregnancy interval without time to replete folate.
    Starting a new pregnancy soon after the prior one can leave folate stores low without supplementation. ACOG

18. Poorly controlled epilepsy leading to hyperthermia or medication changes.
    Seizure-related fever/overheating and last-minute drug switches may add risk; planning helps. AAFP

19. Genetic susceptibility beyond PCP genes.
    NTDs are polygenic; multiple small-effect variants likely contribute alongside environment. PubMed

20. Lack of preconception counseling.
    Missing the window for folic acid (before conception) removes the strongest preventive step. ACOG

Symptoms and clinical features

Many pregnancies with anencephaly end in miscarriage or stillbirth. Liveborn infants with meroanencephaly can have brief survival due to brainstem reflexes, but lack higher brain function. Medscape+1

1. Visible skull defect after birth.
   The back/top of the head is open and not covered by normal bone and skin; abnormal tissue may be seen. Boston Children’s Hospital

2. Missing parts of the brain (especially forebrain).
   Thinking, vision, and voluntary movement centers are absent; only lower brain functions may persist. Boston Children’s Hospital

3. Abnormal facial appearance (“frog-eye” look on imaging).
   Because the upper skull is absent, the orbits can look prominent; this is a classic ultrasound sign. Radiopaedia+1

4. Breathing and basic reflexes may be present.
   Brainstem functions like breathing or startle can occur, but consciousness is absent. New England Journal of Medicine

5. Polyhydramnios during pregnancy.
   Too much amniotic fluid may be noticed because the fetus cannot swallow normally. Fetal Medicine Foundation+1

6. Abnormal fetal head shape on ultrasound.
   Early scans may show the “Mickey Mouse” sign (exencephaly) that progresses to anencephaly signs later. PMC

7. High maternal serum AFP in the second trimester.
   A blood test in pregnancy may be higher than normal, which prompts targeted ultrasound. PMC

8. Decreased fetal movements late in pregnancy (variable).
   Severe brain malformations can affect typical movement patterns. (Imaging confirms the cause.) Medscape

9. Malpresentation or preterm labor (sometimes).
   Polyhydramnios and fetal anomalies can increase these risks. (General obstetric association.) Fetal Medicine Foundation

10. Feeding and swallowing are not compatible with survival.
    Even if born alive, the infant cannot sustain normal feeding due to missing brain structures. Medscape

11. Absent scalp and cranial bones over the defect.
    On exam, there is no protective skull above the orbits. Boston Children’s Hospital

12. Sunken or irregular cranial margins on palpation.
    Clinicians can feel the absent bony skull vault. (Confirmed with imaging.) Radiopaedia

13. Apgar may be low, but brainstem reflexes can persist.
    Scores reflect breathing/heart rate, yet consciousness never develops. New England Journal of Medicine

14. Incompatibility with long-term survival.
    Most affected infants die within hours or days. Medscape

15. Associated spinal defect if craniorachischisis is present.
    In the most severe type, the spine is also open. CDC Archive

Diagnostic tests

A) Physical examination (after birth)

1. Newborn head and scalp inspection.
   Doctors see an open cranial defect with abnormal tissue; this confirms a severe open cranial malformation. Imaging further defines extent. Boston Children’s Hospital

2. Gentle palpation of cranial bones.
   Feeling the margins shows absence of the skull vault above the orbits and along the vertex. Radiopaedia

3. Neurologic bedside checks of primitive reflexes.
   Some reflexes from the brainstem (e.g., startle) may be present, but higher cortical responses are absent. New England Journal of Medicine

4. Apgar scoring at 1 and 5 minutes.
   Basic assessment of heart rate, breathing, tone, irritability, and color informs immediate care needs, but it does not change the diagnosis. (Standard newborn practice.) Medscape

5. General newborn exam for associated anomalies.
   Clinicians look for spine involvement (craniorachischisis) or other organ differences that may affect comfort care. CDC Archive

B) Manual/bedside obstetric assessments (during pregnancy)

6. Fundal-height measurement.
   Rapidly increasing size can suggest polyhydramnios, prompting an ultrasound to check fetal anatomy. Fetal Medicine Foundation

7. Leopold maneuvers (abdominal palpation).
   Although not diagnostic by themselves, abnormal lie or unstable presentation with excess fluid can lead to imaging that finds anencephaly. Fetal Medicine Foundation

8. Fetal heart auscultation or Doppler.
   Presence of a heartbeat does not exclude anencephaly; ultrasound is still required to assess anatomy. Medscape

C) Laboratory and pathological tests

9. Maternal serum AFP (alpha-fetoprotein).
   Elevated AFP in the second trimester is a classic screening clue for open neural tube defects, including anencephaly. PubMed+1

10. Amniotic fluid AFP and acetylcholinesterase (AChE).
    If amniocentesis is done, high AFP and positive AChE support an open NTD. (Used as confirmatory markers.) PMC

11. Chromosomal microarray or karyotype (optional).
    While most anencephaly cases are isolated, genetic testing can evaluate for additional chromosomal problems when the family desires it. PubMed

12. Maternal B12 and folate levels (risk evaluation).
    Checking and correcting B12/folate helps with counseling and prevention in future pregnancies. PMC

13. Medication review (teratogen screen).
    Documenting exposure to valproate or folate-antagonists supports counseling and planning. U.S. Food and Drug Administration

14. Pathology examination after delivery (with consent).
    Examining fetal tissues can confirm the subtype (mero- vs holo-anencephaly) and look for coexisting defects, informing recurrence counseling. PubMed

D) Electrodiagnostic tests (context and limits)

15. Electroencephalography (EEG) in liveborn infants (rarely used).
    EEG reflects cortical activity, which is typically absent in anencephaly; clinical care focuses on comfort, not EEG patterns. New England Journal of Medicine+1

16. Brain-death protocols (not usually applicable).
    Because some brainstem function persists, standard pediatric brain-death criteria often cannot be met in anencephaly. PubMed+1

E) Imaging tests (core of diagnosis)

17. First-trimester ultrasound (10–14 weeks).
    Skull ossification is absent; early signs like the “Mickey Mouse” appearance may be seen, allowing early diagnosis. Fetal Medicine Foundation+1

18. Second-trimester ultrasound (18–22 weeks).
    Classic “frog-face/frog-eye” sign and absence of the cranial vault confirm anencephaly/meroanencephaly. PMC+1

19. 3D/4D ultrasound.
    Three-dimensional views can help parents and clinicians understand the defect more clearly and aid counseling. Fetal Medicine Foundation

20. Fetal MRI (selected cases).
    MRI can further define residual brain structures and check for spinal involvement or other anomalies when needed. ScienceDirect

Non-Pharmacological Treatments (Therapies & Others)

Important note: There is no treatment that reverses meroanencephaly. The following evidence-informed steps are supportive, diagnostic, preventive, or counseling-focused, aligned with major guidelines on NTDs. Lippincott Journals+1

1. Preconception folic acid counseling (core prevention)
   Explain, in simple words, that anyone who can become pregnant should start 400–800 µg folic acid daily before conception and continue through the first 12 weeks to reduce NTD risk. Women with a prior NTD-affected pregnancy are typically advised to take 4 mg/day during the periconception period. Education includes when to start, how long to continue, and the difference between folic acid and dietary folate. USPSTF+2World Health Organization+2

2. Population fortification & public health messaging
   Encourage use of fortified grains and public health campaigns so folate sufficiency is present before a pregnancy is recognized, because the neural tube closes by day 28 post-conception. Community-level fortification reduces NTD rates, especially where supplement access is limited. PMC

3. Early prenatal care and dating
   Timely confirmation of pregnancy and accurate dating enable first-trimester screening at the right time. Early care makes it possible to give folic acid guidance, assess risks, and plan appropriate imaging. Lippincott Journals

4. Targeted prenatal ultrasound
   Second-trimester anatomy ultrasound (and often earlier) detects anencephaly patterns with high accuracy. In meroanencephaly, the skull defect and exposed cerebrovasculosa are typical sonographic findings. PubMed+1

5. Adjunct fetal MRI in selected cases
   Fetal MRI can clarify cranial anatomy when ultrasound views are limited, supporting family counseling and birth planning, though it does not change prognosis. ScienceDirect

6. Genetic counseling
   Counseling covers recurrence risk, multifactorial etiologies, and modifiable risks (folate, diabetes control, medications). It also reviews screening options in future pregnancies. Lippincott Journals

7. Medication risk review (teratogen avoidance)
   Screen and adjust pre-pregnancy medicines that elevate NTD risk (e.g., valproate, high-dose vitamin A/retinoids) and ensure adequate folate if enzyme-inducing antiepileptics are required, in coordination with neurology/obstetrics. Medscape

8. Preconception diabetes optimization
   Tight glucose control before conception lowers congenital anomaly risk, including NTDs; embed diabetes education and coordinated endocrine-obstetric care. Lippincott Journals

9. Weight and nutrition counseling
   Obesity is associated with higher NTD risk; counseling supports healthy weight before pregnancy and reliable folic acid intake (fortified foods + supplements). Lippincott Journals

10. Fever/hyperthermia precautions
    Early pregnancy fevers and hyperthermia may increase NTD risk; counsel on prompt fever treatment and avoiding extreme heat exposures early in gestation. Lippincott Journals

11. Birth planning and perinatal palliative care
    Once meroanencephaly is diagnosed, create a birth plan focused on comfort care for the newborn, parental bonding, memory-making, and symptom relief, recognizing the lethal prognosis. Lippincott Journals

12. Bereavement support
    Offer structured psychosocial support before and after delivery, including remembrance options, peer support, and mental-health referrals to address grief. Lippincott Journals

13. Ethics and options counseling
    In jurisdictions where permitted, discuss the full range of options (continuation of pregnancy with palliative focus vs. termination) in a non-directive, respectful way. Lippincott Journals

14. Lactation planning
    Discuss lactation suppression or expression for comfort; align with parental preferences and medical guidance. This is supportive care for the parent’s wellbeing. Lippincott Journals

15. Coordinated multidisciplinary care
    Integrate maternal-fetal medicine, genetics, neonatology, palliative care, mental health, and social work so families receive consistent, compassionate information. Lippincott Journals

16. Future pregnancy plan
    Before trying again, confirm folic acid strategy (dose and timing), review medications, and schedule an early ultrasound in the next pregnancy. USPSTF+1

17. Community education
    Share simple messages: “Start folic acid before you’re pregnant,” “Keep taking it through 12 weeks,” and “Eat fortified staples.” Public awareness supports primary prevention. CDC

18. RBC folate monitoring (population level)
    At a program level, tracking RBC folate ≥400 ng/mL (≈906 nmol/L) helps evaluate whether a population is protected against NTDs. World Health Organization

19. Documented informed consent and preferences
    Record parents’ values and preferences for labor, delivery, newborn comfort care, photography, and memorialization to honor their choices. Lippincott Journals

20. Accurate, empathetic communication
    Use clear words: “This condition is fatal. Nothing you did caused this. We will support you.” Repetition and written summaries help with recall under stress. Lippincott Journals

Drug Treatments

There is no drug that treats or cures meroanencephaly. The only evidence-based medication strategy is prevention with folic acid before conception and in early pregnancy, plus medications that support the pregnant person’s health and comfort. Below are key medications used in prevention, risk reduction, or peripartum support. Doses are typical examples; prescribing must be individualized by a clinician.

1. Folic acid (standard-risk) — Vitamin (B9); 0.4–0.8 mg daily; start ≥1 month before conception through 12 weeks
   Purpose/Mechanism: Lowers first-occurrence NTD risk by supplying folate needed for DNA synthesis and neural tube closure. Side effects: Usually well-tolerated; rare GI upset. USPSTF+1

2. Folic acid (high-risk/recurrent NTD) — Vitamin; 4 mg daily in periconception period
   Purpose/Mechanism: Reduces recurrent NTD risk (>70% in some data) when started before conception and continued through early first trimester. Side effects: As above. NCBI

3. Prenatal multivitamin with folic acid — Combination; typically 0.4–0.8 mg folic acid daily
   Purpose: Practical way to ensure daily folic acid intake along with other micronutrients; begin before conception. Side effects: Mild nausea for some. USPSTF

4. Insulin (for pregestational diabetes) — Hormone; individualized dosing; continuous use
   Purpose: Optimize glycemic control pre- and early-pregnancy to reduce congenital anomaly risks. Side effects: Hypoglycemia (education needed). Lippincott Journals

5. Metformin (selected patients with type 2 diabetes) — Biguanide; individualized dosing
   Purpose: Part of preconception glycemic optimization where appropriate under specialist care. Side effects: GI upset; rare lactic acidosis in contraindicated settings. Lippincott Journals

6. Alternative antiepileptics when possible (e.g., lamotrigine) — Anticonvulsant; individualized dosing
   Purpose: When clinically feasible, avoid high-risk agents like valproate; ensure high-dose folic acid if any antiepileptic is required. Side effects: Drug-specific; requires neurology oversight. Medscape

7. Acetaminophen (paracetamol) — Analgesic/antipyretic; 500–1000 mg PRN
   Purpose: Treat fever promptly in early pregnancy to lower potential hyperthermia-related risk. Side effects: Generally safe at standard doses; avoid overdose. Lippincott Journals

8. Low-dose aspirin (selected indications) — Antiplatelet; 81 mg daily from 12–16 wks when indicated
   Purpose: Not an NTD drug, but sometimes used for preeclampsia prevention; included here only to clarify it does not prevent NTDs. Side effects: Mild GI upset; bruising. Lippincott Journals

9. Uterotonics for induction/termination where legal (e.g., misoprostol, oxytocin) — Dosing per protocol
   Purpose: If parents choose termination for a lethal fetal anomaly, medications are used under obstetric supervision. Side effects: Cramping, bleeding; clinician-managed. Lippincott Journals

10. Antiemetics for hyperemesis (e.g., doxylamine-pyridoxine) — Per label
    Purpose: Support maternal nutrition/hydration during pregnancy; not NTD-specific but contributes to maternal wellbeing. Side effects: Drowsiness. Lippincott Journals

11. Cabergoline or other lactation-suppression options (case-by-case) — Dopamine agonist; single-dose protocols often used postpartum
    Purpose: If desired after perinatal loss, suppress lactation to reduce physical discomfort. Side effects: Headache, dizziness; medical supervision required. Lippincott Journals

12. Iron and folate-containing prenatal supplements — Per label
    Purpose: Address anemia and maintain folate sufficiency in pregnancy and postpartum. Side effects: Constipation, GI upset. USPSTF

13. Levothyroxine (if hypothyroid) — Hormone; TSH-guided dosing
    Purpose: Optimize maternal thyroid status pre-conception; good overall fetal development support. Side effects: Dose-related; monitored by labs. Lippincott Journals

14. High-dose folate with enzyme-inducing AEDs — Vitamin; often ≥4 mg/day when on certain AEDs
    Purpose: Some clinicians use higher folate with enzyme-inducing antiepileptics to support one-carbon metabolism during neural tube closure. Side effects: As above. Medscape

15. Antipyretics during intercurrent infections — Acetaminophen dosing as above
    Purpose: Fever reduction early in gestation to minimize hyperthermia exposure. Side effects: See above. Lippincott Journals

16. Vaccinations per guidelines — e.g., influenza
    Purpose: Reduce febrile illness risk early in pregnancy; part of general prenatal care. Side effects: Local soreness; rare reactions. Lippincott Journals

17. Folic acid in fortified foods (programmatic “medication”) — 400 µg/day equivalent
    Purpose: Practical, everyday route to achieve protective folate levels in the population. Side effects: None specific. PMC

18. Peripartum analgesia — Epidural or systemic per protocol
    Purpose: Comfort and dignity during labor and delivery in a palliative care plan. Side effects: Procedure-specific. Lippincott Journals

19. Post-loss mental-health pharmacotherapy (if indicated) — SSRIs or others, individualized
    Purpose: Treat severe depression/anxiety after perinatal loss, as part of comprehensive bereavement care. Side effects: Drug-specific; clinician-guided. Lippincott Journals

20. Contraception planning postpartum — Method-specific
    Purpose: Allow time for healing and preconception folate planning before a future pregnancy. Side effects: Method-specific. Lippincott Journals

Dietary Molecular Supplements

Only folic acid has strong evidence for preventing NTDs. Other nutrients may support general health, but they do not replace folic acid for NTD prevention.

1. Folic acid (400–800 µg/day; high-risk 4 mg/day per clinician)
   Supports DNA synthesis and methylation needed during rapid cell division when the neural tube closes; start before conception through 12 weeks. USPSTF+1

2. Folate-rich foods (spinach, lentils, beans, fortified grains; variable “dietary folate equivalents”)
   Diet helps, but folic acid tablets/fortified foods are the proven measures for preventing NTDs at the population level. CDC+1

3. Vitamin B12 (per diet or supplement if deficient)
   Correcting B12 deficiency supports one-carbon metabolism alongside folate; deficiency should be treated, though it is not a substitute for folic acid. Lippincott Journals

4. Choline (adequate intake via diet; supplement only if recommended)
   Choline participates in methylation pathways; adequate intake is part of balanced prenatal nutrition, though evidence for NTD prevention is limited. Lippincott Journals

5. Iron (as part of prenatal vitamins)
   Supports maternal health and oxygen delivery; does not prevent NTDs but maintains wellbeing during pregnancy. Lippincott Journals

6. Iodine (as recommended in prenatal vitamins)
   Supports fetal neurodevelopment broadly; again, not a replacement for folic acid for NTD prevention. Lippincott Journals

7. Vitamin D (per local guidelines if deficient)
   General maternal-fetal benefits; no specific evidence for NTD prevention. Lippincott Journals

8. Omega-3 fatty acids (dietary fish; supplements if advised)
   Support general pregnancy health; not NTD-specific prevention. Lippincott Journals

9. Calcium (dietary or supplement as needed)
   For maternal bone health and preeclampsia risk in some populations; unrelated to NTD prevention. Lippincott Journals

10. Myoinositol (research interest only; consult clinician)
    Investigational for “folate-resistant” NTD in small studies; not standard of care—do not replace folic acid with inositol. Lippincott Journals

Immunity-Booster/Regenerative/Stem-Cell Drugs

There are no immune, regenerative, or stem-cell drugs that repair or reverse meroanencephaly in utero or after birth. Any such claims are unsupported. Care focuses on prevention and compassionate, family-centered management. Lippincott Journals

Surgeries

Surgery cannot create missing skull and brain structures in meroanencephaly; procedures that are routine in spina bifida do not apply. In practice, surgery is not offered because the condition is uniformly fatal; efforts center on comfort care and honoring family choices. PubMed+1

Preventions

1. Start 400–800 µg folic acid daily before pregnancy; continue through 12 weeks. (High-risk: typically 4 mg/day—clinician-guided.) USPSTF+1

2. Eat folate-fortified grains and folate-rich foods in addition to supplements. CDC

3. Plan pregnancies; book early prenatal visits. Lippincott Journals

4. Optimize diabetes before conception. Lippincott Journals

5. Review medications with a clinician; avoid teratogens (e.g., valproate, isotretinoin) when possible. Medscape

6. Manage fever promptly in early pregnancy. Lippincott Journals

7. Aim for a healthy weight before pregnancy. Lippincott Journals

8. Avoid smoking and alcohol; follow prenatal vaccination guidance. Lippincott Journals

9. Consider population fortification benefits; support public health programs. PMC

10. If you had a prior NTD-affected pregnancy, meet a clinician for a high-dose folic acid plan before trying again. NCBI

When to See Doctors

• You plan a pregnancy in the next few months (set up a preconception visit and start folic acid now). USPSTF

• You are of childbearing potential and take antiepileptics or retinoids (get medication review and folate plan). Medscape

• You have diabetes, obesity, or prior NTD history (need tailored prevention strategy and early ultrasound). Lippincott Journals

• You have a positive screening or concerning ultrasound (seek maternal-fetal medicine and genetic counseling). Lippincott Journals

• You received a diagnosis of meroanencephaly (meet neonatology/palliative care to create a supportive birth plan). Lippincott Journals

What to Eat and What to Avoid

What to eat:

1. Choose fortified grains (check the label for folic acid), plus natural folate sources such as lentils, beans, leafy greens, citrus, and avocado. Keep balanced prenatal nutrition with iron, iodine, protein, fruit/vegetables, and healthy fats. Supplements with 400–800 µg folic acid (or 4 mg if high-risk as advised) are still needed because diet alone may not reliably hit protective levels early enough. CDC+1

What to avoid/limit:

1. Avoid alcohol and tobacco; avoid high-dose vitamin A/retinoids and review all over-the-counter/herbal products with your clinician. Manage fevers early; avoid excessive heat exposures in very early pregnancy; and don’t delay starting folic acid until after a missed period—the tube closes around day 28. Medscape+2Lippincott Journals+2

Frequently Asked Questions (FAQs)

1. Is meroanencephaly different from anencephaly?
   Yes. Meroanencephaly is a partial anencephaly pattern with a midline skull defect and exposed cerebrovasculosa; all anencephaly variants are fatal. PubMed+1

2. Can any surgery or medicine fix it?
   No. There is no curative treatment. Care focuses on accurate diagnosis, options counseling, and palliative support. PubMed+1

3. Did I cause this?
   No. Parents do not cause anencephaly. Many factors interact, and even perfect behaviors cannot ensure prevention; folic acid just lowers risk. PMC

4. What is the strongest proven prevention?
   Starting 400–800 µg folic acid daily before pregnancy; high-risk patients often require 4 mg/day per clinician direction. USPSTF+1

5. When does the risk window occur?
   Very early—by 4 weeks after conception the neural tube has closed, so prevention must start before pregnancy is recognized. PMC

6. Can diet alone replace folic acid tablets?
   No. Diet helps, but folic acid supplements/fortified foods are the proven measures to reduce NTDs. CDC

7. Does having diabetes affect risk?
   Yes. Poorly controlled pregestational diabetes raises anomaly risks; optimizing control before conception helps. Lippincott Journals

8. What about antiepileptic drugs?
   Some, like valproate, increase NTD risk; do not stop them on your own—see neurology/obstetrics to adjust therapy and plan folate. Medscape

9. How is the diagnosis made?
   Mostly by prenatal ultrasound; fetal MRI helps in selected cases to detail anatomy. Lippincott Journals+1

10. What happens after diagnosis?
    Families receive non-directive counseling about continuation with palliative care vs. termination where permitted; a birth plan and bereavement support are arranged. Lippincott Journals

11. If I continue the pregnancy, what care is provided?
    Perinatal palliative care focuses on comfort, bonding, and honoring family wishes; survival is brief if any. Lippincott Journals

12. If I end the pregnancy, what should I know?
    Options depend on local laws and gestation; clinicians use standard medications or procedures and provide emotional and physical after-care. Lippincott Journals

13. What is my chance of this happening again?
    Recurrence risk is higher than baseline but can be significantly reduced by high-dose folic acid in the next pregnancy. NCBI

14. Should I check a blood test for folate?
    Routine individual testing isn’t required for most, though RBC folate is used for population monitoring of fortification programs. World Health Organization

15. Where can I find trustworthy guidance?
    See USPSTF folic acid recommendations, WHO guidance, CDC NTD resources, ACOG neural tube defect practice guidance, and academic reviews. Lippincott Journals+3USPSTF+3World Health Organization+3

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: September 17, 2025.

Previous

Anencephaly

Next

Holoanencephaly

Related Articles

Added to wishlistRemoved from wishlist 0

Bilateral Perisylvian Polymicrogyria

Added to wishlistRemoved from wishlist 0

Congenital Axonal Neuropathy with Encephalopathy

Added to wishlistRemoved from wishlist 0

Congenital Absence of the Optic Chiasma

Added to wishlistRemoved from wishlist 0

Congenital CN VI Palsy